Category: Pharmaceutical

250 Pages Oncology Biosimilars Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Oncology Biosimilars to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Oncology Biosimilars market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4800

Digital Transformation in Healthcare Presenting Opportunities for Oncology Biosimilars Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Oncology Biosimilars market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Oncology Biosimilars market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Oncology Biosimilars

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4800

The report offers actionable and valuable market insights of Oncology Biosimilars. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Oncology Biosimilars Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Oncology Biosimilars, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Oncology Biosimilars Market.

Global Oncology biosimilars Market Segmentation

Fact.MR has studied the global oncology biosimilars market with detailed segmentation on the basis of drug class, disease indication, distribution channel, and region.

Drug Class

• G-CSF
• Monoclonal Antibody
• Hematopoietic Agents

Disease Indication

• Breast Cancer
• Non-Small Cell Lung Cancer
• Colorectal Cancer
• Neutropenia
• Blood Cancer
• Leukemia
• Myeloid Leukemia
• Chronic Lymphocytic Leukemia (CLL)
• Non-Hodgkin Lymphoma
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Region

• North America
• Europe
• Asia Pacific
• Rest of the World

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4800

Key Takeaways of Oncology Biosimilars Market Study:

• By drug class, the granulocyte-colony stimulating factor (G-CSF) category shall dominate the oncology biosimilars market, capturing more than 3/5th of the total market share. Rising adoption of chemotherapy is the key growth driver of the segment. However, monoclonal antibodies are set to grow the fastest, expanding 4.0x, attributed to modification of manufacturing facilities to develop complex and effective drugs.
• By disease indication, the blood cancer and neutropenia segments are set to account for the majority of the market share, accounting for 22.3% and 54.7% respectively. Rising FDA approvals for biosimilar products manufactured by leading market players are attributed as key drivers behind the expansion. Examples of such drugs are filgrastim-sndz and filgrastim-aafi.
• By end-user, hospital pharmacies shall expand the fastest, at a whopping CAGR of 29.5%. The growing trend of physicians prescribing biosimilars instead of generic drugs is anticipated to heighten market prospects for the segment. More than half of the global oncology biosimilars market is set to be captured by the hospitals segment.
• Asia-Pacific dominates the oncology biosimilars market. Financial leverage by virtue of collaborations between leading giants is a key growth driver. The region is anticipated to capture over one-third market share, expanding at a CAGR of 30.7% across the forecast period. Trailing behind is North America, with a projected market share of 28.4% and a CAGR of 32.0%. New pipeline drugs are attributed as key growth levers.

“The global oncology biosimilar drugs are finding increased application to treat cancer patients, burgeoned by the rapid phasing out of generic and blockbuster drugs. Key players are concentrating on expanding their product pipeline to provide room for manufacturing these drugs,” concludes a Fact.MR analyst.

Global Oncology Biosimilars Market: Competition Structure:

The global oncology biosimilars market consists of the following market players: Celltrion, Inc., Dr. Reddy’s Laboratories Ltd., Biocon, Teva Pharmaceutical Industries Ltd., and Sandoz International GmBh. This makes it a highly consolidated market. Collectively, these market players account for more than 70% of the market share. In order to increase their market footprints, these companies rely heavily on strengthening their product distribution networks through active collaborations.

Biocon, for instance, announced an exclusive global collaboration with Sandoz on next-generation biosimilars in 2018. Likewise, Dr. Reddy’s collaborated with TR Pharm to launch three biosimilars in Turkey in 2016. Other prominent market players in the global oncology biosimilars market include Pfizer, Inc., Celltrion, Inc., Sandoz International GmBh, STADA Arzneimittel AG and Apotex, Inc. to name a few.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

• Oncology Biosimilars Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
• Oncology Biosimilars Historical volume analysis: The report provides a comparison of Oncology Biosimilars’s historical sales and projected sales performance for 2021-2031.
• Oncology Biosimilars Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Oncology Biosimilars market. It carefully gauges the impact of changing healthcare needs of key demographics globally
• Oncology Biosimilars Consumption by demographics: The report investigates consumer behavior affecting Oncology Biosimilars demand outlook for the assessment period. Effect of their keenness for digital trends on Oncology Biosimilars market is carefully analyzed
• Post COVID consumer spending on Oncology Biosimilars: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Oncology Biosimilars market growth.

More Valuable Insights on Oncology Biosimilars Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Oncology Biosimilars, Sales and Demand of Oncology Biosimilars, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

With constant increase in the usage and wide application of imaging devices such as X-rays, CT scanners, etc., the need for advanced and upgraded medical imaging phantoms that provide better and consistent results has become a priority in the healthcare industry. This has proven to be a key driver for the growth of the medical imaging phantoms market. Moreover, factors such as increased R&D and investments by key players are also important growth factors for this market.

 For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=5119

Fact.MR’s study shows that, medical tourism and increased awareness of radiology studies have proven to boost the market, especially in the Asia Pacific region. Other aspects of market growth are stable government support to increase healthcare activities and better reimbursement policies related to the medical sector, especially in the North American region. Overall, the value of the medical imaging phantoms market is predicted to reach a valuation of over US$ 200 million by 2030.

Key Takeaways from Medical Imaging Phantoms Market Study

• The dominant product in the medical imaging phantoms market is X-ray/fluoroscopy phantoms, accounting for 30% of the total market.
• Hospitals are the key end users of medical imaging phantoms, accounting for around 40% of the market share.
• The market in Asia is expected to witness the fastest growth at a CAGR of 3.6%, based on exponential increase in the population in the region.
• North America is the leading region holding 30% of the total market share, and is expected to maintain its supremacy over the long-term forecast period.

“The COVID-19 pandemic has caused an increase in the number of patients across the world, which has resulted in higher usage of medical imaging devices. As such, the medical imaging phantoms market will not see a decline like most other markets,”says a Fact.MR analyst.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5119

Medical Imaging Phantoms Market: Segmentation

Fact.MR has studied the medical imaging phantoms market with detailed segmentation on the basis of type, end-user, and key regions.

Type

• X-ray/Fluoroscopy Phantoms
• CT Phantoms
• Ultrasound Phantoms
• Nuclear Imaging Phantoms
• MRI Phantoms

End User

• Academic and Research Institutes
• Hospitals
• Diagnostic and Reference Laboratories
• Medical Device Companies

Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5119

Reasons to choose Fact.MR:

• Exhaustive research regarding the market to offer A to Z information.
• Digital technologies to provide innovative business solutions to the clients.
• 24/7 availability of services.
• Interaction with suppliers, vendors, and service providers for precise market landscape.
• Reports tailored as per the requirements of the clients.

For More Insights-https://www.globenewswire.com/news-release/2022/03/09/2400432/0/en/Low-Code-Development-Industry-is-Projected-to-Achieve-a-Global-Market-Size-of-US-187-Bn-by-2032-Currently-US-Accounts-For-the-Largest-Market-Share-in-the-World.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,Dubai, United Arab EmiratesEmail: sales@factmr.com
Visit Our Website: https://www.factmr.com

Global Gamma Probe Devices Market Insights

A gamma probe device is a non-invasive medical device used for interstitial injection of a radionuclide. This device is primarily used to locate sentinel lymph nodes for breast cancer treatment, and is also used in parathyroid surgery. Gamma probe devices are enabling surgeons operate in radio-guided diagnosis and surgery during intra-operation and pre-operation.

It is often difficult to locate tissues such as lymph nodes, tumours, and parathyroid glands within the human body for surgeons. Consequently, the utilization of gamma probe devices in a proper way could facilitate surgeons to go for a smaller incision to locate the tissues of interest.

Due to their primary use for sentinel lymph node mapping and diagnosis of thyroid disease, the gamma probe devices market size is expected to experience noteworthy expansion over the forecast period of 2020 to 2030.

Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=5110

Increasing investments in the gamma probe devices market by major players and rising emphasis on low-cost product development are major factors expected to boost market growth. The global gamma probe devices market was valued at US$ 67 Mn in 2019, and is expected to exhibit a CAGR of around 10% during the forecast period (2020–2030).

Key Takeaways from Gamma Probe Devices Market Study

• The trolley-mounted devices segment, by modality, held maximum value share in the global gamma probe devices market in 2019, owing to their growing preference in hospitals due to convenient localization during surgery.
• By application, the sentinel lymph node uptake segment holds a notable revenue share of around 57% in the global gamma probe devices market, owing to the primary use of sentinel lymph node mapping to locate small and non-palpable breast lesions.
• North America and Europe collectively hold around 70% of the market share, owing to rapid new product launches in these regions.
• In terms of end user, hospitals are expected to dominate the global gamma probe devices market during the forecast period.
• High patient population and increasing government support towards advancing healthcare in Asian countries are expected to propel the growth of the gamma probe devices market in the region.
• The COVID-19 outbreak has thrown most economies and sectors off track. Supply chain disruptions due to manpower shortage and movement restrictions are hampering the progress of the global gamma probe devices market.

 Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5110

“Increasing preference of gamma probe devices for minimally-invasive surgical procedures to counter rising breast and thyroid cancer cases provides a competitive advantage to market players in terms of innovation,” says a Fact.MR analyst.

Key Segments of Gamma Probe Devices Market

Fact.MR’s study on the gamma probe devices market offers information divided into four important segments – modality, application, end-user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Modality

• Handheld Devices
• Benchtop Devices
• Trolley-mounted Devices

Application

• Thyroid Uptake
• Sentinel Lymph Node Uptake
  • Breast Cancer
  • Melanoma
  • Colon Cancer
  • NSCLC
  • Renal Cancer
  • Others

End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 Research Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5110

Crucial insights in the Gamma Probe Devices Market research:

• Underlying macro- and microeconomic factors impacting the growth of the Gamma Probe Devices Market Basic overview of the Gamma Probe Devices Market including market definition, classification, and applications.
• Scrutinization of each Gamma Probe Devices Market player based on mergers & acquisitions, R&D projects, and product launches.
• Adoption trend of Gamma Probe Devices Market across various industries.
• Important regions and countries offering lucrative opportunities to Metal Packaging Coatings Market stakeholders.

For More Insights-https://www.globenewswire.com/news-release/2022/03/09/2400432/0/en/Low-Code-Development-Industry-is-Projected-to-Achieve-a-Global-Market-Size-of-US-187-Bn-by-2032-Currently-US-Accounts-For-the-Largest-Market-Share-in-the-World.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,Dubai, United Arab EmiratesEmail: sales@factmr.com
Visit Our Website: https://www.factmr.com

The latest research report published by Fact.MR on the Survey of Geriatric Medicines Market is intended to offer reliable data on various key factors shaping the growth curve & outlook of Geriatric Medicines market. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders.

The Market survey of Geriatric Medicines offers a comprehensive analysis of diverse features, including production capacities analysis of Geriatric Medicines, demand, product developments, revenue generation, and Size of Geriatric Medicines Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=4746

Key Segments Covered

• Therapeutic Category
  • Analgesic Geriatric Medicines
  • Anti-Hypertensive Geriatric Medicines
  • Statin Geriatric Medicines
  • Anti-Diabetic Geriatric Medicines
  • Proton Pump Inhibitor Geriatric Medicines
  • Anticoagulant Geriatric Medicines
  • Anti-Psychotic Geriatric Medicines
  • Anti-Depressant Geriatric Medicines
• Condition
  • Geriatric Medicines for Cardiovascular Ailments
  • Geriatric Medicines for Arthritis
  • Geriatric Medicines for Diabetes
  • Geriatric Medicines for Neurological Disorders
  • Geriatric Medicines for Cancer
  • Geriatric Medicines for Osteoporosis
  • Geriatric Medicines for Respiratory Disorders
  • Geriatric Medicines for Other Conditions
• Distribution Channel
  • Geriatric Medicines  Sales via Hospital Pharmacies
  • Geriatric Medicines  Sales via Retail Pharmacies
  • Geriatric Medicines  Sales via Online Pharmacies

A comprehensive estimate of the Geriatric Medicines market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Geriatric Medicines during the forecast period. Price point comparison by region with the global average price is also considered in the study.

The Demand analysis of Geriatric Medicines Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Geriatric Medicines Market across the globe.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=4746

Some Notable Offerings by Fact.MR Report on Geriatric Medicines market:

• We will provide you an analysis of the extent to which this Geriatric Medicines market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
• We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
• Also, this report will help you to identify any trends to forecast growth rates.
• The analyzed report will forecast the general tendency for supply and demand.

Some of the Geriatric Medicines Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides: 

• Details regarding latest innovations and development in Geriatric Medicines and how it is gaining customer traction during the forecast period.
• Analysis about the customer demand of the products and how it is likely to evolve in coming years.
• Latest regulations enforced by government bodies and local agencies and their impact on Demand of Geriatric Medicines Market .
• Insights about adoption of new technologies and its influence on the Geriatric Medicines market Size.
• Overview of the impact of COVID-19 on Geriatric Medicines Market and economic disruptions caused by the pandemic.
• Evaluates post-pandemic impact on the Sales of Geriatric Medicines Market during the forecast period.

To get all-in insights on the regional landscape of the Geriatric Medicines Market, buy now:-https://www.factmr.com/checkout/4746

Competitive Landscape

Prominent geriatric medicines manufacturers are emphasizing on a wide array of expansion strategies, comprising of acquisitions, new product launches and collaborations. Some prominent developments in the geriatric medicines industry as follows:

• In August 2021, Pfizer announced that it will acquire Trillium Therapeutics, a clinical stage immune oncology company. The acquisition will work towards improvising the treatments of cancer. According to Pfizer, the deal is likely to be worth US$ 2.26 billion.
• In October 2021, Merck & Co. Inc. published preliminary results of the clinical trials for its Molnupiravir anti-COVID-19 drug. As per the findings, patients administered with this anti-viral halved chances of hospitalization amongst patients exhibiting mild or moderate symptoms. Those administered with this drug showed 100% recovery

After reading the Market insights of Geriatric Medicines Report, readers can:

• Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
• Analyze key regions holding significant share of total Geriatric Medicines market revenue.
• Study the growth outlook of Geriatric Medicines market scenario, including production, consumption, history and forecast.
• Learn consumption pattern and impact of each end use & supply side analysis of Geriatric Medicines market.
• Investigate the recent R&D projects performed by each market player & competitive analysis of Geriatric Medicines Market Players.

How Fact.MR Assists in Making Strategic Moves For Geriatric Medicines Market Manufacturer?

• The data provided in the Geriatric Medicines market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
• The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

For More Insights-https://www.globenewswire.com/news-release/2022/03/09/2400432/0/en/Low-Code-Development-Industry-is-Projected-to-Achieve-a-Global-Market-Size-of-US-187-Bn-by-2032-Currently-US-Accounts-For-the-Largest-Market-Share-in-the-World.html

About Fact.MR:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

 Contact:

4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan

Tel: +1 (888) 863-5616

Pregnancy point of care testing market revenues reached US$ 1.2 billion in 2018, according to new study by research firm Fact.MR. Increasing need for rapid and accurate diagnostics with the emergence of advanced technologies is providing an impetus to the ongoing developments in the pregnancy point of care testing market. The study opines that the market will envisage nearly 5% y-o-y in 2019 over 2018, with growing adoption of innovative technologies likely to redefine future trends.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=3560

Manufacturers are capitalizing on the increasing ubiquity of smartphones by introducing next-generation pregnancy point of care testing devices that can be connected to smartphone applications, finds Fact.MR. Smartphone-based pregnancy point of care testing products are emerging as a promising alternative to traditional laboratory-based diagnostic testing practices. Leading manufacturers are launching innovating products with smartphone connectivity to cater to the end-users’ demand for easy-to-use at-home pregnancy test kits.

In addition, the study also finds that modern smartphone-based pregnancy point of care testing devices are reducing in size, cost, as well as complexity, and this is an important factor to boost growth of the pregnancy point of care testing market. A mounting number of small businesses are entering the pregnancy point of care testing markets in developing regions and launching innovative smartphone-based products at competitive prices to attract consumers in emerging economies. The study opines that increasing number of new players in the market and growing price gap between leading players and new entrants will influence growth of the global pregnancy point of care testing market in the coming decade.

Demand for hCG Urine Test Kits will Continue to Grow

Human chorionic gonadotrophin (hCG) urine test kits accounted for nearly 43% revenue share of the global pregnancy point of care testing market in 2018, and the trend will prevail in the upcoming years, according to the Fact.MR study. The study attributes the rising demand for hCG urine test kits to the burgeoning sales of pregnancy test kits across the world. In 2018, pregnancy test kits accounted for more than half the revenue share in the pregnancy point of care testing market, and higher reliability and accuracy of hCG urine tests in pregnancy point of care testing is bolstering its share in the global market at a rapid pace.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=3560

 

Another factor influencing the demand for hCG urine tests in the pregnancy point of care testing market is the end-users’ preference towards urine testing devices over blood testing devices for pregnancy testing. Through both urine and blood tests can be equally accurate, women are showing a preference to use at-home urine pregnancy test kits primarily due to their simplicity and ease-of-use. The Fact.MR study opines that the adoption of hCG urine tests in pregnancy point of care testing devices will continue to increase in the upcoming years.

North America Accounts for over 50% Revenue Share of the Market

In 2018, the pregnancy point of care testing market in North America was valued at US$ 648 million, according to Fact.MR. Growing prevalence of gynecological and fertility disorders, triggered by changing lifestyle, is leading to the increased adoption of pregnancy point of care testing products across the region.

The Fact.MR study finds that leading manufacturers in North America are adopting advanced technologies for competitive advantages with the launch of more reliable and rapid diagnostics. Despite the ambiguity about the accuracy of commonly available pregnancy point of care testing devices, consumer adoption of these products remains high.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/3560

The Fact.MR study offers the futuristic overview of the pregnancy point of care testing market for the forecast period 2018-2028. The study opines that the market will grow at a healthy 4.5% CAGR during the assessment period.

Why Choose Fact.MR?

1. Deliver updated information on the current industry trends
2. Available 24/7 to facilitate clients with unbiased solutions
3. Embrace digital technologies to offer accurate business ideas
4. Exhaustive supply chain augmentation analysis
5. Provide reports strictly according to the requirements of the clients

For More Insights-https://www.globenewswire.com/news-release/2022/03/09/2400432/0/en/Low-Code-Development-Industry-is-Projected-to-Achieve-a-Global-Market-Size-of-US-187-Bn-by-2032-Currently-US-Accounts-For-the-Largest-Market-Share-in-the-World.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan

Tel: +1 (888) 863-5616